Searching for Genotype-Phenotype Structure: Using Hierarchical Log-Linear Models in Crohn Disease  by Chapman, Juliet M. et al.
ARTICLE
Searching for Genotype-Phenotype Structure:
Using Hierarchical Log-Linear Models in Crohn Disease
Juliet M. Chapman,1 Clive M. Onnie,2 Natalie J. Prescott,2 Sheila A. Fisher,2 John C. Mansﬁeld,3
Christopher G. Mathew,2 Cathryn M. Lewis,2 Claudio J. Verzilli,1 and John C. Whittaker1,*
There has been considerable recent success in the detection of gene-disease associations. We consider here the development of tools that
facilitate the more detailed characterization of the effect of a genetic variant on disease. We replace the simplistic classiﬁcation of indi-
viduals according to a single binary disease indicator with classiﬁcation according to a number of subphenotypes. This more accurately
reﬂects the underlying biological complexity of the disease process, but it poses additional analytical difﬁculties. Notably, the subphe-
notypes that make up a particular disease are typically highly associated, and it becomes difﬁcult to distinguish which genes might be
causing which subphenotypes. Such problems arise in many complex diseases. Here, we concentrate on an application to Crohn disease
(CD). We consider this problem as one of model selection based upon log-linear models, ﬁtted in a Bayesian framework via reversible-
jump Metropolis-Hastings approach. We evaluate the performance of our suggested approach with a simple simulation study and then
apply the method to a real data example in CD, revealing a sparse disease structure. Most notably, the associated NOD2.908G/R muta-
tion appears to be directly related to more severe disease behaviors, whereas the other two associated NOD2 variants, 1007L/FS and
702R/W, are more generally related to disease in the small bowel (ileum and jejenum). The ATG16L1.300T/A variant appears to
be directly associated with only disease of the small bowel.Introduction
Many diseases are phenotypically complex, being divided
into a number of possibly overlapping disease classes or
subsets. We refer to these subsets as ‘‘subphenotypes’’ of
the overall phenotype. We consider below the example
of Crohn disease (CD; inﬂammatory bowel disease [MIM
266600]), which has a number of clinical types or behav-
iors and can also occur at a number of different locations.
Treatment of disease as a single affected or unaffected cate-
gorization ignores this complexity, and though this is
reasonable in the ﬁrst phase of discovery of genetic associ-
ations, it is important in subsequent studies to advance our
understanding of how associated genes are related to
particular subphenotypes of the overall disease and how
these subphenotypes are related to one another.
The main problem in analysis is that subphenotypes of
a particular disease are very often highly associated with
one another, so that an individual with one subphenotype
is much more likely to have another subphenotype,
compared to the population as a whole. This means that it
canbeparticularly difﬁcult to localizewhich gene is causing
which subphenotype by the usual univariate approaches,
because a gene causing an effect on one phenotype can
appear to be having an effect on other correlated pheno-
types as well.
Our aim is to deduce which genes are directly related to
which subphenotypes and which subphenotypes are
directly inﬂuencing one another. In order to do this, we
need to deﬁne both direct and indirect associations. An asso-
ciation between two variables is indirect if the relationship is178 The American Journal of Human Genetics 84, 178–187, Februarentirelymediated (or confounded) by the effect of other vari-
ables. A direct association is therefore one that is not entirely
inﬂuenced (or confounded) by another variable and one
that, given the data, represents some true direct relation-
ship between two (or more) variables. Notice that this is
equivalent to the concepts of conditional independence
and dependence in the literature on undirected graphical
models: two variables (or nodes) in a graph are dependent
if directly linked by an edge or are conditionally indepen-
dent if other nodes are present on all paths between them.
Within this paper, we suggest modeling the data jointly
by using a Poisson log-linear model,1,2 which deﬁnes
a model for the cell counts of a contingency table. Within
the following section, we explain brieﬂy how this model
can be deﬁned in terms of a series of interaction parameters
that equate to direct relationships between variables. We
can infer which direct relationships are important or unim-
portant by determining which interaction parameters are
necessary and which can be dropped from the model.
Notice that not all log-linear models can be represented as
an undirected graph; in particular, a graph corresponding
to amodel containingonlyﬁrst-order interactionsbetween,
say, three variablesmaybe represented as a complete clique,
whichwould wrongly imply the presence of interactions of
higher order (three-way in the example here).3
Although most multifactorial diseases have moderate
numbers of subphenotypes and known associations are
relatively rare, the model spaces we expect to encounter
are huge because there are very many possible interactions
(one for each cell of the contingency table, in fact) and,
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reason, we focus upon a Bayesian-model averaging scheme.
This not only allows us to search themodel spacemore efﬁ-
ciently, but it also means that we are able to include prior
information that downweights models with many high
order interaction terms, in order to prevent overﬁtting.
Within the Material and Methods section and the
Appendix, we give details of the Poisson log-linear model1
and the reversible-jump Metropolis-Hastings algorithm
(RJMH)4 that we implement. Then, we investigate the efﬁ-
ciency of this approach, compared to usual univariate anal-
yses, through simulations and thenapply thismethod to an
example in which we examine the relationships between
CD subphenotypes and a number ofwell-known associated
loci. Our simulations show that the RJMH approach can
distinguish well between direct and indirect associations
and, thus, has advantages over the usual univariate anal-
ysis. The application to CD helps to clarify which genes
are directly associated to which subphenotypes.
Material and Methods
The Model: Poisson Log-Linear Model
Our aim is to model all variables, i.e., genotypes and subpheno-
types, within a single model; therefore, there is no need for a nota-
tional distinction between genotypes and subphenotypes. If we
assume thatwehaveG genotypes,X1,.,XG, and S subphenotypes,
Y1,., YS, we can pool these into one set of p ¼ (G þ S) variables,
Z1,., ZP, in which the ﬁrst G variables are genotypes and the last
S variables are subphenotypes. We say that the pth variable has
Lp levels (for p ¼ 1,., P), and for ease of notation, we label these
levels from 0 to (Lp  1). A genotype may, for example, have L ¼ 3
different levels, labeled as 0, 1, 2 (we do not assume Hardy-Wein-
berg equilibrium).
The data can be displayed within a P-dimensional contingency
table, with each dimension corresponding to a different variable.
The number of cells within this table is equal to I, the product of
the number of levels across all variables (I ¼QPp¼1 Lp). Each cell
corresponds to a unique realization of (Z1, .., ZP), and we can
deﬁne cell i as (z1i,., zPi).
Our log-linear model assumes that for cell i in 1:I, the observed
cell counts ni have a Poisson distribution with mean mi, and that
the log of expected cell counts, log(mi), is given by a linear model
including the baseline parameter, b0, themain effects of each of the
variables, and interaction parameters of various order. The total
number of possible parameters is always equal to the number of
cells in the contingency table (I).
By dropping parameters from the saturated model, which
contains all possible interaction parameters, we can decide which
interaction parameters are important—that is, which have large
posterior probabilities associated to them—for modeling the
data. Those interaction parameters that are important within our
model can inform us about likely direct (and indirect) associations.
Two variables are deemed to be directly associated only if there
exists at least one parameter including the two variables that is
judged to be important. Two variables are indirectly linked if the
set of important parameters include a chain of overlapping direct
relationships relating the two variables.
To illustrate this, consider a data set with three binary variables,
eachwith just two levels; 0 and1. Thecontingency tablehas2323
2 ¼ 8 cells, and the saturated model isThe AmericalogðmiÞ ¼ b0 þ b1z1i þ b2z2i þ b3z3i þ b12z1iz2i þ b13z1iz3i þ b23z2iz3i
þ b123z1iz2iz3i,
in which b0 is the baseline parameter; b1, b2, and b3 are the main
effectsof variables 1, 2, and3;b12,b13, andb23 are thepairwise inter-
actions between variables (1 and 2), (1 and 3), and (2 and 3); and
b123 is the three-way interaction between variables (1, 2, and 3).
Suppose we search across the set of all models and ﬁnd evidence
that the parameters {b0, b1, b2, b3, b12, b23} are nonzero but that
no other parameters are needed for adequate modeling of the
data. The ﬁrst pairwise interaction parameter, b12, tells us that vari-
ables 1 and 2 are likely to be directly associated, and b23 tells us that
variables 2 and 3 are directly associated. Because there is no param-
eter containing both 1 and 3, we know that these variables are not
directly associated.However, theyare indirectly associated,because
variable 1 is directly associated with variable 2 and variable 2 is
directly associated with variable 3.
Therefore, determination of which models are the most probable
tells us about direct and indirect relationships between genotypes
andsubphenotypes,aswellasdirectgenotype-genotypeassociations
and phenotype-phenotype associations. Given the complicated
nature of the models considered, we implement a reversible-jump
Metropolis-Hastings algorithm to search across the model space.
In fact, the algorithm that we consider is restricted to a subclass
of log-linear models known as the set of hierarchical models. These
are models that contain only parameters for which all implied
parameters are also included in the model. Each parameter relates
to an interaction between particular levels of one ormore variables
and, as such, is deﬁned by these variable levels. All subparameters
of this parameter are those parameters that are deﬁned by a subset
of these variable levels. For example, the subparameters of b12,
above, are b1, b2, and b0. This means that b12 can only be included
in a hierarchical model if these three parameters are also included
within the model. The search algorithm is described below, and in
further detail within the Appendix.
Search for Important Parameters: Reversible-Jump
Metropolis-Hastings
Even with moderate numbers of variables, the space of all possible
models is very large. Moreover, many of these models may have
similar likelihoods. Hence, choice of a single ‘‘best’’ model is likely
to be highly unstable, andmodel averaging across sampledmodels
is preferable.5We adopt a Bayesian approach,whichwenowbrieﬂy
describe. Additional details are given in the Appendix.
Denote a model bym, the corresponding set of parameters by b,
and the relevant set of variables by Z. We wish to calculate the
probability of the model and parameters, given the data, that is
the posterior probability of the model and parameters P(m, bjZ) ¼
const3L(Z; m, b) P(m, b), in which L(Z;m, b) is the likelihood of
the data given the parameter values b and the model m and
P(m, b) is the joint prior ofm and b. This prior distribution deﬁnes
our prior beliefs about themodel and its parameters. An additional
beneﬁt of the Bayesian approach is that we can include as prior
information our belief that complex models with many complex,
high-level interactions are unlikely, which reduces the problem of
overﬁtting.
We use RJMH to approximate the required posterior distribution
by sampling from it. The RJMH sampling scheme starts at an
initial model and set of parameter values, m(0) and b(0). To sample
the next model and set of parameters, m(1) and b(1), we propose
a move from the current state to another model and/or set ofn Journal of Human Genetics 84, 178–187, February 13, 2009 179
parameter values,m* and b*, using a proposal function q(m*, b*jm,
b). We then accept these proposed values as the next sample with
probability equal to the Metropolis-Hastings ratio:
MHR ¼ LðZ;m
, bÞPðm, bÞ
LðZ;m, bÞPðm, bÞ 3
qðm, b jm, bÞ
qðm, b jm, bÞ:
If this new set of values is accepted, the proposed set is accepted
asm(1) and b (1). Otherwise, the sample value remains equal to the
current sample value, i.e., m(1) ¼ m(0) and b (1) ¼ b (0). It can be
shown that this produces a sequence of samples that converge
to the required posterior distribution.4,6 More details about the
scheme used are given in the Appendix.
We need to choose a prior distribution for both the parameter
values and likely model distribution. As in the research by Della-
portas and Forster,7 we choose independent normal priors for
the values of each parameter included in the model, each with
zero mean and precision 1/t2 ¼ 0.001. In terms of the model prior,
we expect sparse models with lower-order interaction parameters,
with higher-order interactions rarely included. Therefore, we
assign all parameters of a given size (1 to P) equal prior probabili-
ties of being included in the model and allow this probability to
decrease rapidly as the size of the interactions decreases, making
higher-order terms less likely. The prior for a particular model is,
then, formed as the product of these parameter-inclusion prior
probabilities, for all parameters in the current model, again
favoring sparse models. The code used for ﬁtting the models is
available from J.M.C.’s webpage (see Web Resources).
Results
Simulation Study
The aim of this simple simulation study is to explore the
performance and accuracy of the RJMH approach and, in
particular, to illustrate the differences between this
approach and a simple univariate analysis, which simply
looks for association between any pair of variables. For
simplicity, we assume that we have six binary variables,
Z1,., Z6, and a single true underlying model. We assume
that all log-linear main effects are equal to log(0.2/(1 –
0.2)) ¼ 1.39, which gives a frequency of 0.2 within the
set of controls. We set most log-linear pairwise interactions
to be 0 (i.e., no direct association) and set six of them to be
nonzero; namely, those between Z1 and Z2 (log(2.72) ¼ 1),
Z1 and Z3, Z2 and Z6 (log(1.5)¼ 0.41), Z3 and Z4, Z3 and Z5,
and Z5 and Z6 (log(2) ¼ 0.69). These pairwise parameters
can be thought of as log of the relative risks between the
two variables involved. The corresponding model for the
mean expected count of cell i (on the log scale) can be
written as log(mi)¼1.39z1i 1.39z2i 1.39z3i 1.39z4i
1.39z5i  1.39z6i þ 1z1iz2i þ 10.41z1iz3i þ 0.41z2iz6i þ
0.69z3iz4i þ 0.69z3iz5i þ 0.69z5iz6i.
A graphical representation of this model is shown in
Figure 1. Those familiar with graphical models should
note that this is an interaction graph; lines between nodes
represent pairwise interactions.3
On the basis of thismodel, we simulated ten data sets and
ran theRJMHmethodupon eachdata set, using 30, 000 iter-
ations, dropping the ﬁrst 10, 000 as burn-in iterations and180 The American Journal of Human Genetics 84, 178–187, Februarythinning by 40, leaving a sample of 1000 models. For each
data set, we then calculated the posterior probability of
inclusion for all pairwise interactions. Table 1 shows these
posterior probabilities for each pairwise interaction, within
each of the ten data sets. Those in the top six rows are those
that are within the true underlying model, i.e., true posi-
tives, and those in the bottom nine rows are those that are
notwithin the truemodel and should not be detected.Care-
ful consideration of the speciﬁcity and sensitivity of
different cutoff values suggests the use of 0.4 as an appro-
priate cutoff value fordeﬁning importantparameters.Across
the ten simulateddata sets, this equates to amean speciﬁcity
of 1 and a mean sensitivity of 0.95. Using this cutoff value
of 0.4, we can see that the RJMH approach always gets
rid of untrue associations but occasionally misses out on
some true associations—namely, the (1,3) interaction in
samples 7 and 10, shown in bold font within the table,
and the (2,6) interaction in sample 5. Notice, however,
considering Table 2, that the (1,3) interaction is also missed
by the usual univariate analysis in sample 10, as is the (2,6)
interactionwithin sample 5.Within the univariate analysis,
we simply carried out all possible pairwise univariate anal-
yses, using simple score tests. Table 2 shows the results
from this standard analysis. Now, if we let any pair with
a p value smaller than or equal to 0.05 deﬁne a signiﬁcant
ﬁnding, we see that although we pick up practically all of
the true interactions that the RJMH method picks up,
many other false associations are also detected. These p
values incorrectlydeemedsigniﬁcantarehighlightedwithin
the table with bold font, as are the two p values that were
Figure 1. Interaction graph representing the true model
underlying the simulated data for binary nodes Z1 to Z6
Lines between nodes represent true pairwise interactions between
the two nodes.13, 2009
Table 1. Posterior Probabilities of all Pairwise Interactions for Ten Simulated Data Sets
Posterior Probability
Interaction 1 2 3 4 5 6 7 8 9 10
(1,2) 1 1 1 1 1 1 1 1 1 1
(1,3) 0.978 0.949 1 0.615 1 1 0.161 1 0.95 0.018
(2,6) 0.587 0.491 0.664 1 0.040 0.935 0.426 0.618 0.484 1
(3,4) 1 1 1 1 1 1 1 1 1 1
(3,5) 1 1 1 1 1 1 1 1 1 1
(5,6) 1 1 1 1 1 1 1 1 1 1
(1,4) 0.01 0.033 0.013 0.034 0.009 0.007 0.013 0.01 0.016 0.041
(1,5) 0.006 0.031 0.014 0.026 0.008 0.012 0.016 0.015 0.012 0.009
(1,6) 0.025 0.01 0.008 0.013 0.012 0.064 0.013 0.025 0.009 0.015
(2,3) 0.013 0.015 0.018 0.026 0.031 0.031 0.018 0.085 0.014 0.011
(2,4) 0.015 0.020 0.009 0.01 0.018 0.013 0.017 0.012 0.008 0.009
(2,5) 0.013 0.015 0.003 0.029 0.013 0.014 0.009 0.128 0.016 0.016
(3,6) 0.005 0.049 0.019 0.026 0.009 0.014 0.026 0.003 0.015 0.036
(4,5) 0.01 0.039 0.002 0.02 0.004 0.005 0.013 0.013 0.009 0.012
(4,6) 0.013 0.012 0.016 0.01 0.02 0.027 0.017 0.011 0.014 0.019
False positives and negatives are highlighted in bold type.incorrectly deemed nonsigniﬁcant. Even if we use the unre-
alistically stringent Bonferroni correction and consider only
those p values smaller than 0.0033 (¼ 0.05/15) to be signif-
icant, we observe that many of these false interactions are
still detected. Notice, in particular, that with the univariate
method, the (3,6) and (4,5) interactions are often incorrectly
found to be signiﬁcant, which makes sense if one considers
the structure of the data, which indirectly links variables 3
and 6, as well as 4 and 5 (see Figure 2). This nicely demon-
strates our point that the RJMH approach is able to distin-
guishwell between direct and indirect associations, whereas
standard univariate approaches are unable to discriminate
easily between the two.
Application to Crohn Disease
The data set consists of 1019 cases and 2757 controls, from
numerous British and European sources. CD patients wereThe Americarecruited after ethical review and obtaining of informed
consent from Guy’s and St. Thomas’s Hospital London,
St. Mark’s Hospital London, and the Royal Victoria Inﬁr-
mary Newcastle, as previously described by Onnie et al.8
and Precott et al.9 The diagnosis of CD was made via estab-
lished criteria of clinical, radiologic, and endoscopic anal-
ysis and fromhistology reports. Of the population controls,
1371 were obtained from the 1958 British birth cohort
(National Child Development Study) and the remaining
1386 were the noninﬂammatory-disease controls collected
at Guy’s and St. Thomas’s Hospital London (reported in
Onnie et al.10), the Royal Victoria Inﬁrmary Newcastle,
and the European Collection of Cell Cultures (ECACC).
A summary of this data is given in Table 3.
CD has a number of subphenotypes, and these can
themselves be split into two classes: (1) location of disease
and (2) behavior of disease. CD can occur at any locationTable 2. Pairwise p Values of all Pairwise Interactions for Ten Simulated Data Sets
Pairwise p Values
Interaction 1 2 3 4 5 6 7 8 9 10
(1,2) 8.1022 9.1020 2.1016 2.1031 1.1020 2.1022 4.1021 3.1022 1.1016 7.1029
(1,3) 5.106 6.105 3.107 6.104 8.107 1.108 1.102 6.108 8.105 0.27
(2,6) 7.104 2.103 6.104 3.106 0.073 1.104 3.103 3.104 8.104 2.106
(3,4) 3.1025 2.1032 8.1022 4.1022 3.1034 7.1037 7.1024 1.1031 4.1026 8.1024
(3,5) 7.1029 4.1034 7.1031 5.1028 3.1019 1.1025 3.1028 2.1034 1.1028 2.1030
(5,6) 5.1023 2.1029 2.1026 6.1027 9.1026 3.1026 3.1036 3.1021 4.1038 3.1032
(1,4) 0.80 0.86 0.18 0.69 0.11 0.059 0.26 0.37 0.07 0.24
(1,5) 0.066 0.17 0.0046 0.035 0.14 0.028 0.52 0.035 0.59 0.47
(1,6) 0.052 0.57 0.38 0.053 0.53 0.64 0.67 0.031 0.82 0.77
(2,3) 0.24 0.56 0.0065 0.96 0.02 0.78 0.31 0.00022 0.75 0.99
(2,4) 0.87 0.23 0.54 0.80 0.22 0.90 0.29 0.6 0.74 0.94
(2,5) 0.84 0.56 0.29 0.69 0.45 0.25 0.53 0.48 0.059 0.18
(3,6) 0.0081 5.106 0.028 0.22 0.02 0.00097 0.11 0.00058 0.0061 0.095
(4,5) 0.00058 0.047 0.01 0.0037 0.0092 0.011 0.067 5.106 0.032 0.003
(4,6) 0.46 0.18 0.63 0.83 0.12 0.66 0.079 0.37 0.1 0.037
False positives and negatives are highlighted in bold type.n Journal of Human Genetics 84, 178–187, February 13, 2009 181
along the gastric tract, including the ileum, jejenum,
colon, rectum, and anus. For the purposes of our analysis,
we will combine diseases of the ileum and jejenum and call
this location the small bowel. Therefore, we classify the
areas of interest into small bowel, colon, rectum, and
anus, and we will denote these by binary variables, which
equal 1 when an individual has disease at that place and
0 otherwise. CD can also be classed into different disease
behaviors—namely, inﬂammatory, internal ﬁstulating,
perianal ﬁstulating, and stenosing.
Gene-identiﬁcation studies for CD have been highly
successful,11,12 and we focus here on three of the earliest
genes and regions to be associated with CD: NOD2 (MIM
605956), the 5q31 region (MIM 606348), and ATG16L1
Figure 2. Interaction graph represent-
ing the output of the real Crohn disease
data
Nodes represent all genotypes and all sub-
phenotypes and lines between nodes repre-
sent marginal pairwise associations with
posterior probabilities greater than 0.4.
NG, NL, NR represent the 3 NOD2 muta-
tions; 908G > R, 1007L > FS, 702R > W,
5q represents 5q31 mutation, AT the
ATG16L1 gene and Ste, Per, Fis, Inf repre-
sent the disease behaviors; stenosing,
perianal fistulating, internal fistulating
and inflammatory. Notice that any clique
in the graph does not imply the presence
of higher order interactions, since not all
log-linear models are graphical.3
Table 3. Summary of Crohn Disease Data
Minor-Allele Frequencies
Locus Controls (% Missing) Cases (% Missing)
NOD2.908G/R 0.010 (17) 0.034 (3)
NOD2.1007L/FS 0.017 (31) 0.071 (4)
NOD2.702R/W 0.050 (34) 0.101 (7)
5q31 0.423 (27) 0.482 (8)
ATG16L1 0.488 (58) 0.404 (17)
Subphenotype Frequencies
Subphenotype Controls Cases
small bowel 0 0.727
colon 0 0.566
rectum 0 0.215
anus 0 0.245
inflammatory 0 1
internal fistulating 0 0.215
perianal fistulating 0 0.244
stenotic 0 0.503
(MIM 611081). Within these three
loci, we model association with
the variants 908G/R (rs2066845),
1007L/FS (rs2066847) and 702R/
W (rs2066844) in NOD2,13–15 IGR2063 (no rs number
assigned) in the 5q31 region,16,17 and ATG16L1.300T/A
(rs2241880), all of which are strongly associated with CD
in this population.9
These eight binary subphenotype variables and ﬁve
ternary genotype variables can be jointly represented
within a 13-dimensional contingency table. This table
has (28)3(35) ¼ 62208 cells and, therefore, parameters.
Notice that, although any subphenotype can occur with
any genotype and any location of disease with any disease
behavior, those cells for which there is a location of disease
but no disease behavior, or vice-versa, are not possible.
This means that we must modify the likelihood deﬁned
above and restrict the models allowed accordingly. The
Appendix gives details of the required modiﬁcations to
likelihood and proposal distribution.
We apply the RJMHmethod to this contingency table of
data and gain a sample of models drawn from the required
posterior distribution. We carried out 50, 000 iterations of
this procedure.We judged the procedure to have converged
well before theﬁrst 10, 000 iterations,whichwere discarded
as burn in. Posterior draws are thinned every 40 iterations,
leaving a sample of 1000 models. The posterior probability
for the inclusion of each parameter is then simply calcu-
lated as the proportion of these models that include that
parameter. Following the suggestions of Dellaportas and
Forster,7 we set the variances of the prior and proposal
normal distributions of the parameter values as t2 ¼ 1 and
s2 ¼ 2, respectively. We sampled new parameter values,
keeping themodel ﬁxed with a probability of 0.25. Because
some of the genotype data were missing, we also sampled
new missing genotypes every 50 iterations. Varying the
value of the prior precision on regression coefﬁcients did
not materially change the results. See Appendix for details.182 The American Journal of Human Genetics 84, 178–187, February 13, 2009
Table 4. Posterior Probabilities of Direct Interactions within the Crohn Disease Data Set
Node Genotype Location Behavior Posterior Probability
(1,11) NOD2.908G/R internal fistulating 1
(5,6) ATG16L1 small bowel 1
(8,9) rectum, anus 1
(9,10) anus Inflammatory 1
(9,12) anus perianal fistulating 1
(7,8) colon, rectum 1
(7,10) colon inflammatory 1
(6,8) small bowel, rectum 1
(6,10) small bowel inflammatory 1
(6,13) small bowel stenosing 1
(10,12) inflammatory, perianal fistulating 1
(10,13) inflammatory, stenosing 1
(9,10,12) anus inflammatory, perianal fistulating 1
(3,6) NOD2.702R/W small bowel 0.96
(6,9) small bowel, anus 0.92
(10,11) inflammatory, internal fistulating 0.917
(7,13) colon Stenosing 0.87
(6,11) small bowel internal fistulating 0.87
(7,9) colon, anus 0.811
(2,6) NOD2.1007L/FS small bowel 0.785
(1,2) NOD2.908G/R, NOD2.1007L/FS 0.679
(1,13) NOD2.908G/R stenosing 0.603
(2,5) NOD2.1007L/FS, ATG16L1 0.42
(4,9) 5q31 anus 0.398
Each row refers to an interaction found to have posterior probability greater than 0.4. Column 1 contains the node numbers involved within each inter-
action, columns 2 to 4 contain the names of genotypes, locations, and behaviors involved within each interaction, and column 5 gives the posterior prob-
ability of that interaction.Looking at theposterior probabilities of singlemodels,we
ﬁnd that the maximum posterior probability of any model
in the sample is 0.005. This is indicative of the fact that the
posterior model distribution is highly dispersed. For this
reason, itmakes sense to average over allmodels and simply
consider the proportion of samples that include each of the
interaction parameters within the model; i.e., consider the
marginal probabilities of interaction terms. Table 4 shows
the posterior probabilities for all pairwise interactions
with a posterior probability greater than 0.4.We have drop-
ped simple main effects from this table, because these all
have a posterior probability equal to 1 and do not tell us
anything more about the underlying structure of the data.
Note that in our model, each genotype is represented as
a variable with three levels (i.e., two nonbaseline levels)
and, therefore, interactions arenot deﬁnedonly by the vari-
ables that interact but also by the level of the variables that
are interacting.However, our focus is not uponwhich levels
are interacting but simply upon which variables are inter-
acting, and therefore, we suppress the variable-level infor-
mation and report only interactions for the level that has
the highest posterior probability.
Table 4 may be more easily represented in terms of the
graph in Figure 2. As discussed above, it should be stressed,
particularly to those familiar with graphical models, that
this representation is closely related to interaction graphs
rather than to fully ﬂedged undirected graphs, given that
each line on the graph refers to a simple pairwise interac-
tion and any subgraph need not necessarily be saturated.The AmericOn the basis of Table 4 and Figure 2, we are able to make
some interesting observations, not only about the direct
associations that arepresentbut also about thosedirect asso-
ciations that are absent. We see that the NOD2.1007L/FS
and 702R/W mutations are directly associated only to
disease in the small bowel, whereas the NOD2.908G/R
mutation seems to be directly related just to the two severe
disease behaviors; internal ﬁstulating and stenosing. A
number of studies have previously found the association
between NOD2 variants and ileal disease to be stronger
than that between NOD2 variants and CD in general,18,19
and this result suggests that, in fact, any general relation
between NOD2 and CD may be the consequence of direct
association with small-bowel or ileal disease, as well as
internal ﬁstulating and stenosing disease behaviors. We
ﬁnd that ATG16L1 has a direct effect upon disease of the
small bowel. This agrees with the ﬁndings of Prescott
et al.,9 who found ATG16L1 to be associated with disease
in the ileum but not with disease in the colon. When
choosing a posterior probability cutoff of 0.4 to deﬁne
important interactions, we ﬁnd that the SNP in the 5q31
region does not appear to be directly related with any other
variable (either genotype or subphenotype). However, we
doseeadirect associationbetween this SNPandanaldisease,
with a near important posterior probability of 0.398, suggest-
ing that perhaps we should not ignore this association,
particularly since this has been suggested previously by Ar-
muzzi et al.,20 who found association only between 5q31
and perianal disease. Many locations of disease are relatedan Journal of Human Genetics 84, 178–187, February 13, 2009 183
to other disease locations, as may be expected, given that
disease locations are clearly highly correlated with one
another. Similarly, all noninﬂammatory disease behaviors
are related to inﬂammatory disease behavior. There is also
evidence of a three-way interaction between disease in the
anus, inﬂammatory disease, andperianalﬁstulatingdisease.
In terms of direct relationships between location of disease
anddisease behavior, we ﬁnd that disease of the small bowel
is related to all disease behaviors except perianal ﬁstulating
disease, colonic disease is directly related to both inﬂamma-
tory and stenosing disease, and anal disease is directly asso-
ciated with inﬂammatory and perianal ﬁstulating disease.
Discussion
Once genetic associations have been found, we wish to
further investigate the inﬂuence of the associated genes
with disease, and one important aspect of this is deter-
mining which genes are related to which subphenotypes.
Standard univariate analyses are unable to do this because
of high correlations between subphenotypes. Instead, we
suggest the use of Bayesian model-selection procedures
within the set of hierarchical log-linearmodels. Our simula-
tion study shows the ability of this approach to distinguish
between direct and indirect associations.
The method gives interesting insights into the probable
genetic structure of CD. The direct relationships between
disease locationanddiseasebehaviormakebiological sense.
In terms of direct relationships between genes and disease
subphenotypes, it appears that the effects of the NOD2
mutations may differ, such that the G908R mutation
is related to more severe disease behaviors—namely,
internal ﬁstulating and stenosing—and the 1007L/FS
and 702R/W mutations appear to be directly related
only to disease of the small bowel. ATG16L1 is directly
associated to disease in the small bowel, as well as to
NOD2.1007L/FS, and the locus within the 5q31 region
appears to be weakly directly related to anal disease.
Although the last association is questionable, it has been
detected previously.20 However, notice that, as discussed
earlier, any direct and indirect associations have to be inter-
preted within the context of the set of variables studied.
Wehave chosen tousehierarchical log-linearmodels. It is,
of course, possible that the truemodel is not in this class; for
example, a model in which subphenotype is due to a pure
interaction between loci is nonhierarchical, because the
nearest hierarchicalmodelwould includebothmain effects.
If suchmodels are common, a more general class of models
might be preferred. Inversely, restriction to a simpler class of
models would give increased power when the true model is
well approximated by a member of this simpler class. For
example, if the threeNOD2 loci actmultiplicatively to cause
disease,wewouldbe likely tohavemorepower todetect this
interaction if we restricted ourselves to multiplicative
models, rather than allowing each single locus genotype
tohave adifferent effect on thedisease.However, at present,
little is known about the relationship between multiple184 The American Journal of Human Genetics 84, 178–187, Februargenetic factors and phenotypically complex disease, such
as CD.We believe that hierarchical log-linear models repre-
sent a realistic and ﬂexible set of models and provide an
attractive compromise between parsimony and the desire
to represent potential biological complexity.
Appendix
Log-Linear Models and the Poisson Likelihood
If I represents the set of all possible cells within this contin-
gency table, ni the observed count within cell i, and mi the
expected count within this cell (for i ¼ 1, ., I), we can
model the contingency table data using a Poisson likeli-
hood, which may be written in the following form:
LðZ;mÞ ¼ QI
i¼1
expðmiÞ3mnii
nk
¼ const3 QI
i¼1
exp
mi3mnii
¼ const3 exp
PI
i¼1
ni3 logðmiÞ 
PI
i¼1
mi

:
It is well known that the Poisson likelihood for cell
counts gives equivalent results to the multinomial likeli-
hood for cell probabilities but omits the need to directly
normalize across all cells and is therefore a more practical
model to use.1 The model deﬁned above is parameterized
by the set of mI, and therefore, there is one parameter for
each cell; hence, this model represents the most saturated
model possible for the data, which cannot inform us about
the underlying structure.
A log-linear model, however, allows us to deﬁne a model
for each expected cell count (mi), and this model can then
be used for information about the underlying structure. A
log-linear model deﬁnes each cell mean in terms of a sum
of ‘‘interaction’’ parameters present within that cell. Each
‘‘interaction’’ parameter corresponds to a subset of the
nonbaseline variable levels, and there are an equal number
of these parameters as there are cells in the contingency
table. We let j index the set of all possible parameters and
let bj represent interaction parameter j, for j ¼ 1, ., J
(where J ¼ I in the case of the saturated model). We also
represent cell i by the vector zi ¼ (zi1, ., ziP)) and let the
function bj(.) be equal to bj if cell i includes parameter j
and zero otherwise. The model for the log of the expected
cell mean can then be written as:
logðmiÞ ¼
XJ
j¼1
bj

zi

:
Plugging this into the Poisson likelihood, we can re-
express our likelihood as:
LðZ;mÞ ¼ const3 exp
 XI
i¼1
ni3
XJ
j¼1
bj

zi
XI
i¼1
exp
3
 XJ
j¼1
bj

zi
!!
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This new parameterization allows us to make use of the
ﬂexibility of these log-linear models by dropping parame-
ters from the saturated model, so that we can ﬁnd the
most parsimonious models that ﬁt the data with the fewest
degrees of complexity. This equates to our taking a subset
m of 1, ., J to deﬁne our model and summing across all
j in m rather than across all parameters 1, ., J. Note that
there exists a correspondence between the parameters of
a log-linear model and those of a (perhaps more familiar)
logistic-regression model, such that the pairwise interac-
tion between, say, Z1 and Z2 is equivalent to the main-
effect parameter of the logistic regression of either Z1 on
Z2 or Z2 on Z1. This equivalence extends to interactions
of all sizes, so that a log-linear three-way interaction
parameter is equivalent to a logistic pairwise interaction
between two of the variables, in which the third variable
is the outcome of the regression, and so on.
Because we restrict ourselves to the set of hierarchical
models, all models may be deﬁned unambiguously by the
maximal set of parameters that are not subparameters of
any other parameters contained in the model. These
maximal parameters are known as the generators of the
model, and we shall deﬁne these by G. Each hierarchical
model also has a set of dual generators. These are the set
of parameters that are ‘‘next up’’ from the generators. In
other words, these are the set of parameters that are not
contained in the model, but all subparameters of these
parameters are included in the model. We will denote
this set by D. We have decided to restrict attention to the
subclass of hierarchical log-linear models, because not
only is the model space smaller but the steps of the
model-search approach that are proposedmakemore sense
in this scenario and are more likely to be accepted. Both
the generators and dual generators are important when
this approach is used.
Reversible-Jump Metropolis-Hastings: Proposal
Distributions
We have decided to consider only hierarchical models.
Following the method of Dellaportas and Forster,7 we
allow three possible proposal steps. The ﬁrst step is to
drop a parameter from themodel. Because we are interested
only in hierarchical models, the only parameters that we
can legally drop are the set known as the generators of
the model, because the resulting model would otherwise
contain parameters for which not all subparameters belong
to the model. Therefore, so long as the set of generators is
not simply the set containing a only, we will randomly
propose one of the generators to drop from the model.
The second step is to add a parameter to the model. Again,
because we are interested only in hierarchical models, the
only terms that we can legally add are those within a partic-
ular set known as the dual generators of the model. So long
as this model is nonempty, we randomly propose one of
the dual generators to add to the current model. Because
we are adding a term, we also need to propose a value for
this parameter. We will simply sample this value fromThe America normal distribution with zero mean and variance s2,
independent of both the model and the other parameter
values. The ﬁnal proposal type is known as the null
move, because the model remains unchanged and we
simply update the parameter values of the current model.
Theoretically, this step is unnecessary for guaranteeing
convergence, but it allows us to move around the space
more quickly and effectively. Within this step, we simply
update all parameters separately, in a random order, using
a simple normal proposal with mean equal to the current
value of the parameter and variance equal to s2. Note
that ideally, we would use some form of Gibbs sampling
approach, as did Dellaportas and Forster,7 which means
that we would update each parameter every time we carry
out the null step. However, this can be impractically slow
and time consuming for larger problems. Alternatively,
we repeat the random sequence of updates a given number
of times, T, in a single ‘‘null’’ step. Within the applications
of this paper, we choose T ¼ 10. When the null step is not
sampled, the drop step and the add step are proposed with
equal probability, so long as both are possible; otherwise,
the only possible step is selected automatically.
Prior Distributions
The joint prior distribution of m and b can be written as
P(m, b) ¼ P(m)3P(bjm).
As did Dellaportas and Forster,7 we chose independent
normal priors for each parameter included in the model,
each with zero mean and precision 1/t2¼ 0.001. We found
that results were not very sensitive to variance in the prior
precision. As an uninformative prior on the model, they
chose tomake all models equally likely. Although this prior
at ﬁrst appears uninformative, it is in fact informative on
the number of terms in the model, because (for general
log-linear models) it has its maximum at jIj2 parameters,
which is very large even for problems of moderate size.
We expect that in reality, the models with main effects
and perhaps a few pairwise interactions would be the
most likely models and that higher-order interactions
would become more and more unlikely the higher the
order becomes. We therefore wish to choose a prior that
reﬂects this information. A possible prior can be deﬁned
by assigning all sizes of interaction (from 1:P) with a prob-
ability so that p(s) deﬁnes the probability of a parameter of
size equal to s, given that all subparameters are in the
model. If we let sa deﬁne the size and order of interaction
a (i.e., the number of variables included in a), then the
prior for a particular model can be formed as the product
of p(sa) across all parameters within the model, such that
model m has a prior probability of 3
PðmÞ ¼ const3
Y
a˛m
pðsaÞ,
in which we choose pðsaÞfesa and const is the normalizing
constant that ensures that the sum across all models is
equal to 1. Note that this need not be calculated, because
it falls out of the Metropolis-Hastings ratio.an Journal of Human Genetics 84, 178–187, February 13, 2009 185
Missing-Data Update
Although we assume that there are no missing data and no
misclassiﬁcation of the disease phenotypes, we allow for
missing genotype data. Therefore, we need to treat this
missing data as an unobserved random variable that can
be updated as part of the RJMH algorithm. For simplicity,
we ﬁx the algorithm to update the missing data every
50 iterations. At each of these updates, the proposal sepa-
rately updates each individual, such that new values for
all missing loci in that individual are independently
sampled from 0, 1, and 2 with equal probability (1/3).
The Metropolis-Hastings ratio for accepting or rejecting
the proposed data set for this individual is then based
just upon the likelihood ratio.
Dealing with Structural Zeros
In our application, in which we have multiple classiﬁca-
tion classes, there is a small set of cells that are not
possible. In usual contingency-table terms, these are
referred to as ‘‘structural zeros’’ (distinguished from
sampling zeros, in which a cell is possible but observed
to have a zero count). In our speciﬁc case, these structural
zeros occur because an individual with CD at a particular
location must also have at least one behavior of CD and
vice-versa. So it is impossible for an individual with no
location of disease to have a disease behavior or an indi-
vidual with no disease behavior to have a location of
disease. In our case, this means that there will be
(35)3((24  1) þ (24  1)) ¼ 7290 contingency-table cells
that are structural zeros. This has two implications for
our RJMH method. The ﬁrst is simply the need for a small
adjustment to the likelihood, so as to adjust the set of all
possible parameters, I, so that it no longer includes these
structural zeros; therefore, within the likelihood we only
sum the expected mean cell frequencies over those cells
that are not structural zeros. The second adjustment is
slightly more complicated. Just as sampling zeros in the
frequentist framework can cause problems with ﬁtting
some parameters, structural zeros can cause problems
with ﬁtting some parameters in the Bayesian framework.
The problem is simply that the maximum number of
parameters that we can ﬁt in our model is equal to the
number of possible cells in the table and when some cells
are not possible we ﬁnd that we can no longer ﬁt some of
the parameters. Therefore, we need to restrict the set of all
possible parameters to a set that is ﬁttable given the struc-
tural zeros. If there areQ cells that are structural zeros, then
we need to select Q parameters that we can drop, so that
the rest of the parameters are ﬁttable. This group of
‘‘illegal’’ parameters contains all parameters that contain
the interaction between the highest level of all of the
‘‘behavior’’ variables and the highest level of one or more
‘‘location’’ variables, as well as all those parameters that
contain the interaction between the highest level of all
of the ‘‘location’’ variables and the highest level of one
or more ‘‘behavior’’ variables. Note that this second point
is really a problem only for very small numbers of variables186 The American Journal of Human Genetics 84, 178–187, Februaryand when there is no weighting of the prior against highly
parameterized models. In the application that we consider,
this point becomes academic.
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